💊 Hear from #iDR25 speakers, Christophe Lahorte and Yorick Peterse, how iDR brings together funders, regulators, patients, scientists and more to develop a better regulatory framework for drug repurposing.
Join us in Brussels on 12-13 May
➡️ Discover more: www.remedi4all.org/iDR26
At #iDR25, patient advocate Kim McClellan shared how a repurposed drug gave her back her voice. REMEDi4ALL, co-organiser of #iDR25 & coordinated by EATRIS, continues to advance #PatientCentred innovation in drug repurposing. Join us for #iDR26 in May 2026 in Brussels 👉 https://remedi4all.org/idr26
🎬 #iDR25 highlight reel is here!
Relive the best moments from Amsterdam, where 300+ participants & 60+ experts came together to explore how AI, innovative trials & collaboration can transform #DrugRepurposing.
➡️ Watch the recap on the Conference hub: https://remedi4all.org/idr25-conference/
REMEDi4ALL and #iDR25 have been featured in Forbes, highlighting case studies in malaria, MND, CVS and RRP, the role of adaptive trial designs and patient input, and the need for stronger US–EU collaboration in drug repurposing.
📖 https://loom.ly/iY05I1A
#iDR25 and the work of EATRIS & @remedi4all.bsky.social has been featured in @forbes.com – covering case studies, adaptive trial design, patient input, and the call for stronger US–EU collaboration in #DrugRepurposing.
👉 Read the article here: eatris.eu/news/eatris-...
Hope for new drugs headline
My latest: Medicines Reimagined – #Repurposing Drugs For New Indications via @forbes www.forbes.com/sites/judyst... #FDA #DrugRepurposing #MotorNeuronDisease #Malaria #RespiratoryPapilloma #HPV #Remedi4All #iDR25
It was a blast to participate in the international Drug Repurposing Conference #iDR25 in Amsterdam earlier this month!
Our strengthened tie with the European ecosystem is opening up more doors for collaborations.
Stay tuned and sign up to our newsletter: bit.ly/3XTmfJp
#iDR25 by @remedi4all.bsky.social!
2.5 days full of patient stories, AI, policy discussions, trial designs & networking to make #DrugRepurposing the new normal💊🌍
👏Big thanks to all teams & speakers!
📰Great recap by @oriolguell.bsky.social
EN: loom.ly/qzQoFDY
#RareDiseases #PatientCentredResearch
📣#iDR25 making headlines!
El País spotlights drug repurposing advances — including how a hypertension pill may help children with epidermolysis bullosa.
Great to see REMEDi4ALL and #iDR25 featured as key #DrugRepurposing initiatives!
🔗Read more: loom.ly/qzQoFDY
#iDR25 – That’s a wrap!
🌍 300+ joined us in Amsterdam for two days of panels, posters, and powerful discussions on smarter routes to repurposed medicines.
👥 Thanks to our speakers and attendees for your insights, energy & contributions.
📖Highlights: remedi4all.org/idr25-wraps-...
🚀 ERDERA at #iDR25 🚀Daria Julkowska spotlighted how #ERDERA is shaping patient-centred #DrugRepurposing to tackle unmet needs in #RareDiseases. Thanks to @remedi4all.bsky.social & #BeaconForRareDisease for sparking powerful conversations! 👏 Until next time! #PublicHealth #InnovationInHealth
🎉 What a conference! 🎉 Two energising days at #IDR25 in Amsterdam with Teamit as part of the organising & comms team for @remedi4all.bsky.social. Insightful talks, powerful patient stories & great connections. Thanks Beacon for Rare Diseases, #ZonMw! 👏 Until next time! #DrugRepurposing #EUHealth
Day 2 of #iDR25 is in full swing! We're tackling #DrugRepurposing, AI, #ClinicalTrial innovation, #PatientSccess, & more.
📸 Daria Julkowska, @erdera.bsky.social: “ #ERDERA aims to deliver real health gains for #RareDisease patients in the next decade.” #DrugRepurposing
🎉 We are on Day 2 of #iDR25! We have an amazing array of speakers from LifeArc, the European Medicines Agency, UCL, Tiefenbacher Group, Chan Zuckerberg Initiative, Medicines for Europe, to name only a few.
➡️ Check all the tracks here: remedi4all.org/2025-interna... #DrugRepurposing #PatientCentric
This afternoon at #iDR25: three parallel tracks!
🤖 Advances in AI for Drug Repurposing
💊 Repurposing for the Under-Served
🔗 Pathways to Patient Access
Global experts, big topics. Check the agenda: remedi4all.org/2025-interna...
🤔 Which one would you follow?
💊 The International Drug Repurposing Conference #iDR25 has started in Amsterdam. #Chemotargets will be represented by Nikola Panajotovikj, exploring with the drug repurposing community ways to unlock the potential of existing drugs for the benefit of patients.
👉 lnkd.in/eb32WZd5
#iDR25 #R4ALL
This afternoon at #iDR25: three parallel tracks!
🤖 Advances in AI for Drug Repurposing
💊 Repurposing for the Under-Served
🔗 Pathways to Patient Access
Global experts, big topics. Check the agenda: remedi4all.org/2025-interna...
🤔 Which one would you follow?
🔴 We're live from #iDR25 discussing AI-enhanced clinical decisions, European platform trials tackling major depression #MMD, initiatives in repurposing for children and substance use, and more.
New and exciting insights to initiatives in the #DrugRepurposing landscape!
At #iDR25 in #amsterdam. Compelling talk by Kim McClellan on #RareDisease and #HPV
Wonder how she feels about antivaxxers heading FDA now…
🌟 #iDR25 has officially begun! This morning we explore EU funding, patient voices & national strategies. Proud to hear from @eatris.bsky.social, Beacon for Rare Diseases, ZonMw, Dutch Ministry of Health & more! Let’s go!
📸 Anton Ussi (EATRIS-ERIC) opening the conference.
The #iDR25 workshops are in full flow in Amsterdam! The Health Technology Assessment session has just concluded, and the Regulatory workshop is about to begin, featuring the #REPURPOLIS board game.
➡️ Check out the packed agenda for the next 2 days: remedi4all.org/2025-interna...
✈️An early start this morning for Chris as he headed off to Amsterdam for #iDR25.
💊Entitled Medicines Reimagined - Unlocking the potential of existing drugs for patient benefit, the conference aims to advance the field of drug repurposing by bringing together key opinion leaders.📰Stay tuned
Honoured to be asked to speak at #iDR25 in Amsterdam, Netherlands next week to share insights at the Innovative #ClinicalTrial designs track in connection with #MND/ #ALS and the MND-SMART Trial from a patient perspective highlighting the power of collaboration. #DrugRepurposing #RareDiseases
Sponsor Announcement! We're delighted to welcome LifeArc as an #iDR25 Gold Sponsor!
LifeArc transforms science into impact – aiming for a world where no one with a rare disease is left behind. More on LifeArc: www.lifearc.org
🎟️ #iDR25 tickets: remedi4all.org/2025-interna...
We're excited to welcome you to Amsterdam next week for #iDR25 - the 2025 International Drug Repurposing Conference!
Expect a dynamic programme with expert speakers all focused on advancing repurposing for patient benefit.
🎟️ Last tickets: loom.ly/mYozy3E
Just one week left for the 2025 International #DrugRepurposing conference #iDR25!! As a partner of the #R4ALL project, #Chemotargets will be there represented by Nikola Panajotovikj.
👉 remedi4all.org/2025-interna...
#REMEDi4ALL #EATRIS #BeaconforRareDiseases #DrugRepurposing #HorizonEU
🚨 Don't miss it!
🗓️ May 7, 09:00
🗣️Dalila Julkowska, from CNAG's Scientific Advisory Board, will participate in #iDR25, discussing support for rare disease repurposing projects
➡️More information: remedi4all.org/2025-interna...
#RareDiseases #Research
📣 In 2 weeks, Daria Julkowska will speak at #iDR25 in Amsterdam, hosted by @remedi4all.bsky.social 💊🔬 Joined by a panel of experts, the session "Repurposing for the under-served", will explore vital questions on repurposing for under-served populations. #drugrepurposing #RareDiseases #ERDERA
🚨 Breaking news: Dompé is an #iDR25 Platinum Sponsor!
With 130+ years of history, Dompé blends a family-run business with the innovation of a start-up. Active across the pharma value chain, they're a great fit for our AI track.
🔗 Learn more: loom.ly/xGqLsX4
